Zentalis Pharmaceuticals Inc (ZNTL)
11.71
+0.60
(+5.40%)
USD |
NASDAQ |
May 03, 16:00
11.71
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Enterprise Value: 348.13M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 348.13M |
| May 02, 2024 | 305.56M |
| May 01, 2024 | 319.75M |
| April 30, 2024 | 302.01M |
| April 29, 2024 | 327.55M |
| April 26, 2024 | 302.01M |
| April 25, 2024 | 296.69M |
| April 24, 2024 | 352.39M |
| April 23, 2024 | 409.16M |
| April 22, 2024 | 439.67M |
| April 19, 2024 | 436.83M |
| April 18, 2024 | 407.03M |
| April 17, 2024 | 419.09M |
| April 16, 2024 | 431.16M |
| April 15, 2024 | 458.83M |
| April 12, 2024 | 468.76M |
| April 11, 2024 | 468.76M |
| April 10, 2024 | 562.43M |
| April 09, 2024 | 634.10M |
| April 08, 2024 | 554.63M |
| April 05, 2024 | 587.27M |
| April 04, 2024 | 604.30M |
| April 03, 2024 | 625.59M |
| April 02, 2024 | 541.14M |
| April 01, 2024 | 661.78M |
| Date | Value |
|---|---|
| March 28, 2024 | 635.52M |
| March 27, 2024 | 595.07M |
| March 26, 2024 | 517.02M |
| March 25, 2024 | 480.83M |
| March 22, 2024 | 485.79M |
| March 21, 2024 | 490.05M |
| March 20, 2024 | 489.34M |
| March 19, 2024 | 504.95M |
| March 18, 2024 | 500.70M |
| March 15, 2024 | 533.34M |
| March 14, 2024 | 518.08M |
| March 13, 2024 | 606.43M |
| March 12, 2024 | 566.33M |
| March 11, 2024 | 506.37M |
| March 08, 2024 | 609.27M |
| March 07, 2024 | 570.95M |
| March 06, 2024 | 551.79M |
| March 05, 2024 | 529.08M |
| March 04, 2024 | 547.53M |
| March 01, 2024 | 601.46M |
| February 29, 2024 | 575.20M |
| February 28, 2024 | 616.36M |
| February 27, 2024 | 561.01M |
| February 26, 2024 | 516.31M |
| February 23, 2024 | 485.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
179.83M
Minimum
Nov 10 2023
3.485B
Maximum
Dec 31 2021
1.355B
Average
1.214B
Median
Enterprise Value Benchmarks
| Revolution Medicines Inc | 4.768B |
| Day One Biopharmaceuticals Inc | 1.134B |
| Perspective Therapeutics Inc | 1.055B |
| Electromed Inc | 148.76M |
| Xtant Medical Holdings Inc | 126.76M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -60.92M |
| Total Expenses (Quarterly) | 67.92M |
| EPS Diluted (Quarterly) | -0.83 |
| Earnings Yield | -38.77% |